The role of protein kinases in the steroidogenic actions of a-melanocyte-stimulating hormone (a-MSH), angiotensin II (AngII) and corticotropin (ACTH) in the rat adrenal zona glomerulosa was examined. Ro3l-8220, a potent selective inhibitor of protein kinase C (PKC), inhibited both AnglI-and a-MSH-stimulated aldosterone secretion but had no effect on aldosterone secretion in response to ACTH. The effect of Ro3l-8220 on PKC activity was measured in subcellular fractions. Basal PKC activity was higher in cytosol than in membrane or nuclear fractions. Incubation of the zona glomerulosa with either a-MSH or AnglI resulted in significant increases in PKC activity in the nuclear and cytosolic fractions and decreases in the membrane fraction. These effects were all inhibited by Ro3l-8220. ACTH caused a significant increase in nuclear PKC activity only, and this was inhibited by Ro3 1-8220 without any significant INTRODUCTION Angiotensin II (AnglI) and corticotropin (ACTH), the two major stimuli of aldosterone secretion, act through two distinct signal-transduction pathways. ACTH stimulates adenylate cyclase activity thereby increasing cyclic AMP which in turn activates cyclic AMP-dependent protein kinase [1, 2] . In the rat adrenal zona glomerulosa, a-melanocyte-stimulating hormone (a-MSH) shares a common mechanism of action with AngIl; both peptides activate phospholipase C resulting in the formation of inositol 1 ,4,5-trisphosphate which raises intracellular Ca2l and diacylglycerol concentrations, which activates protein kinase C (PKC) [3] [4] [5] .
INTRODUCTION
Angiotensin II (AnglI) and corticotropin (ACTH), the two major stimuli of aldosterone secretion, act through two distinct signal-transduction pathways. ACTH stimulates adenylate cyclase activity thereby increasing cyclic AMP which in turn activates cyclic AMP-dependent protein kinase [1, 2] . In the rat adrenal zona glomerulosa, a-melanocyte-stimulating hormone (a-MSH) shares a common mechanism of action with AngIl; both peptides activate phospholipase C resulting in the formation of inositol 1 ,4,5-trisphosphate which raises intracellular Ca2l and diacylglycerol concentrations, which activates protein kinase C (PKC) [3] [4] [5] .
PKC, originally isolated from rat brain cytosol, has been found to mediate a wide range of cellular responses [6] . Studies have shown that cell stimulation by agents known to activate phospholipase C is followed by translocation of PKC from the cytosol to the membrane [6] [7] [8] , and it is at the plasma membrane that PKC is activated by diacylglycerol [9] .
The mechanism of signal transduction at the plasma membrane level appears to be well understood whereas events associated with the cell nucleus are less clear. It was initially documented that PKC is either absent from or poorly represented in the nucleus [6] . However, further studies suggest that PKC phosphorylates a number of nuclear proteins and may be involved in the regulation of transcription and expression of protooncogenes such as c-fos, c-jun and c-ref-I [10] [11] [12] [13] [14] [15] . Previous studies from this laboratory showed that effects such as AnglI and ac-MSH cause translocation of PKC from the cytosol to the membrane [16] ; however, their effects on nuclear PKC have not been investigated. In the present study experiments were carried effect on the steroidogenic response to ACTH, suggesting that PKC translocation in response to ACTH may be involved in another aspect of adrenal cellular function. Tyrosine phosphorylation has not previously been considered to be an important component of the response of adrenocortical cells to peptide hormones. Both AnglI and a-MSH were found to activate tyrosine kinase, but ACTH had no effect, observations that have not been previously reported. Tyrphostin 23, a specific antagonist of tyrosine kinases, inhibited aldosterone secretion in response to AnglI and a-MSH, but not ACTH. These data confirm the importance of PKC in the adrenocortical response to AnglI and a-MSH, and, furthermore, indicate that tyrosine kinase may play a critical role in the steroidogenic actions of AnglI and a-MSH in the rat adrenal zona glomerulosa.
out to elucidate the role of nuclear PKC in rat adrenal steroidogenesis.
Tyrosine kinase activity and tyrosine phosphorylation of cellular proteins are usually considered to be fundamental elements of the mitogenic response to various growth factors, particularly epidermal growth factor [17] [18] [19] . Kinase activity usually results in the phosphorylation of cellular proteins which may then be activated [20] [21] [22] . There has been some speculation that tyrosine kinase activation is secondary to activation of PKC in some tissues. PKC has been postulated, on the basis of observations that phorbol ester alone can activate tyrosine kinase and enhance tyrosine phosphorylation [23] [24] [25] , to play an important role. There have been no reports to date on the possible role of tyrosine kinase in response to AnglI, a-MSH or ACTH on the rat adrenal zona glomerulosa in vitro.
These experiments were designed to examine the roles of PKC and tyrosine kinase in Angll-, a-MSH-and ACTH-stimulated aldosterone secretion using the antagonists Ro31-8220, a potent selective PKC inhibitor [26, 27] and tyrphostin 23, a specific inhibitor of tyrosine kinases [28] . [31] .
Peptide assay of tyrosine kinase activity
The basis of the assay is the separation of the 32P-labelled peptide substrate from unchanged [32P]ATP by adsorption of the former to phosphocellulose paper at low pH [32] . Whole adrenal capsules were obtained as described above and preincubated in 5 ml of KRBG for 60 min. The preincubation media were then discarded and the capsules incubated in fresh KRBG with increasing concentrations of Angll, a-MSH or ACTH in the presence or absence of Ro31-8220 or tyrphostin 23 for 60 min. After incubation, the media were discarded and the capsules homogenized in kinase assay buffer [ 
RESULTS

Effects of inhibitors on steroid secretion
AnglI, ac-MSH and ACTH caused dose-dependent increases in aldosterone production from the rat adrenal glomerulosa (Figures la-ic) . Threshold stimulation of aldosterone secretion was 10-10 M for Angll and a-MSH and 10-2 M for ACTH.
Dose-dependent inhibitory studies were carried out to determine the optimal concentration of the inhibitors to use in this study (results not shown). It was ascertained that Ro3l-8220 should be used at 150 nM, calphostin C at 50 nM, tyrphostin 23 at 50 nM and genistein at 500 nM. Figure 1 shows that the actions of Angll and ca-MSH on aldosterone production were significantly attenuated by the PKC inhibitors Ro31-8220 and calphostin C (P < 0.001) causing up to 75 % inhibition. These inhibitors had no effect on ACTH-stimulated aldosterone secretion. Phorbol 12-myristate 13-acetate (PMA; 10-to 10-M) also stimulated aldosterone production which was significantly inhibited by Ro3l-8220 and calphostin C (results not shown).
The protein tyrosine kinase inhibitors tyrphostin 23 and genistein, at a concentration of 50 nM and 500 nM respectively, had no effect on aldosterone secretion in response to ACTH (Figure lc) . However, tyrphostin 23 did cause significant attenuation of AnglI-and a-MSH-induced steroid output from rat zona glomerulosa in vitro (Figures la and lb) by lowering the maximum aldosterone response to both these stimulants. Effects of inhibitors on PKC activity In control (unstimulated) tissue, PKC activity was mainly found in the cytosolic fraction, about 80 %, with 12 % and 8 % in the membrane and nuclear fractions respectively ( Table 1) . The effects of Angll, a-MSH and ACTH stimulation on the subcellular distribution of PKC activity in whole glomerulosa tissue are shown in Table 1 . Both membrane-and nuclearassociated PKC activities were significantly increased after incubation with 10-8 M Angll and cytosolic activity was decreased compared with control. A similar translocation of PKC activity was seen with 10-8 M a-MSH. ACTH had no effect on membrane-associated PKC. However, it did cause a decrease in cytosolic PKC and a significant increase in nuclear PKC activity (P < 0.05).
To study the effects ofinhibitors on PKC activation, tissue was exposed to 150 nM Ro3l-8220, 50 nM calphostin C, 50 nM tyrphostin 23 or 500 nM genistein before incubation with the various stimulants. The PKC inhibitors, Ro3l-8220 and calphostin C, caused significant decreases in membrane and nuclear PKC activity in response to either AnglI or a-MSH and a corresponding increase in cytosolic enzyme activity (Table 1) . In other words, Ro31-8220 and calphostin C prevented translocation of PKC activity in response to AnglI or a-MSH. The increase in nuclear PKC activity in response to ACTH was also inhibited by Ro3l-8220. (30-50%) in AnglI-and a-MSH-stimulated nuclear PKC activity associated with a similar increase in cytosolic PKC activity. The tyrosine kinase inhibitors had no effect on ACTHstimulated nuclear PKC.
Effects of inhibitors on tyrosine kinase activity
The ability of these stimulants to activate tyrosine kinase was studied using Raytide as a substrate for the kinase assays. All kinase assays were carried out with a substrate concentration of 0.25 mg/ml which was found to give optimal activity (results not shown). Figure 2 shows 32P incorporation by tyrosine kinase. Angll and a-MSH dose-dependently stimulated tyrosine kinase activity. Threshold stimulation was at 10-10 M for Angll and a-MSH (Figure 2a and 2b) . The actions of AnglI and a-MSH on tyrosine kinase activity were significantly (P < 0.001) inhibited by the protein tyrosine kinase inhibitor tyrphostin 23. ACTH did not stimulate tyrosine kinase activity at any concentration used (Figure 2c) .
The PKC inhibitor Ro3 1-8220 also caused significant attenuation of AnglI-and a.-MSH-induced tyrosine kinase activity from rat glomerulosa in vitro (Figures 2a and 2b) . Genistein and calphostin C also inhibited AnglI-and a-MSH-induced tyrosine kinase activity (results not shown) although these antagonists were less effective than tyrphostin 23.
DISCUSSION
The present study provides new insights into the role of protein kinases in aldosterone secretion stimulated from the rat zona glomerulosa. When PKC was inhibited by either Ro3l-8220 or calphostin C, Angll-and a-MSH-induced aldosterone production was considerably decreased (Figures la and lb) . These inhibitors had no effect on ACTH-stimulated aldosterone secretion. These data confirm our previous findings, indicating the importance of the PKC-signalling pathway in aldosterone output in response to AnglI or a-MSH, but not ACTH. The results are different from those obtained by other workers [33, 34] who reported that PKC did not play an important role in AngIlstimulated steroid production. The reasons for this discrepancy are not entirely clear; however, differences in experimental procedure may account for part of the difference. The use of whole zona glomerulosa tissue appears to be an important factor in observing the PKC-dependent aspect of aldosterone secretion [30] . In the present study, AngIl induced a more than 5-fold increase in aldosterone production, whereas other workers did not obtain this [33, 34] . The latter based their conclusions on observations of down-regulation of PKC by pretreating cells with phorbol ester, but recent reports [35, 36] have shown that pretreatment of adrenocortical cells with phorbol esters may have other non-specific effects.
When PKC activity itself was studied, it was interesting to discover enzyme activity in the nucleus. Little progress has been made towards characterization of protein kinases that act at the nucleus, although a number of nuclear serine and theronine kinases are documented [37] [38] [39] [40] . There is conflicting evidence about nuclear PKC. Nishizuka [6] negated the possibility of PKC being located in the nucleus on the basis of immunocytochemical analysis. However, there is evidence to suggest a nuclear role for PKC, for instance phosphorylation ofnuclear proteins [10, 39, 41] . In view of mounting evidence for a functional role of PKC at the nucleus, two aspects are worth considering. First, is PKC translocated from the cytosol to the nucleus, and secondly, is there endogenous PKC present in the nucleus? The present study supports both possibilities. Treatment with ACTH did not alter membrane content of PKC, but nuclear PKC activity was enhanced. However, it is evident that translocation of PKC to the nucleus is not important for the steroidogenic effects of ACTH as the PKC inhibitors, Ro31-8220 and calphostin C, had no effect on ACTH-stimulated aldosterone secretion. PKC has been reported to be involved in the regulation of transcription factors [12, 14, 40, 43, 44] . It is possible to speculate on the mechanism by which receptortriggered signal transduction induces transcription of regulatory factors. Recent reports have suggested that ACTH is capable of stimulating protein kinases, PKC in particular, which may be involved in transmitting the hormonal signal to the nucleus to regulate genes such as c-fos and c-jun in adrenal glands [45] [46] [47] .
In the study presented here, a novel biochemical signalling pathway in the rat adrenal zona glomerulosa has been identified. AngIl and a-MSH stimulated tyrosine kinase activity in a dosedependent manner, whereas ACTH did not (Figure 2 ). Specific tyrosine kinase inhibitors, tyrphostin and genistein, caused almost complete abolition of tyrosine kinase activity in the zona glomerulosa in response to these peptide hormones, and, furthermore, inhibited steroidogenesis. It has been reported that AnglI can stimulate tyrosine kinase in other cell types such as rat aortic smooth-muscle cells and glomerular mesangial cells [25, 48, 49] . In these cells, AngIl has a significant mitogenic effect which appears to be mediated by tyrosine phosphorylation. These workers also suggest that PKC activation is an important intermediate step necessary for tyrosine kinase activation. Further evidence for this observation comes from studies carried out using phorbol esters. Experiments with both PKC inhibitors and depletion demonstrated that PKC was necessary but not sufficient for tyrosine kinase activity [44, 49, 50] . Sequential activation of intracellular protein kinases has been associated with signal transduction in a number of tissues [49] [50] [51] [52] [53] . Although Ro31-8220 is a specific inhibitor of PKC activity, it also had a significant inhibitory effect on AnglI-and a-MSH-induced tyrosine kinase activity (Figure 2 ). This suggests that PKC may trigger activation of tyrosine kinase. Despite the apparent blocking of the PKC-dependent pathway by Ro31-8220, agoniststimulated tyrosine kinase activity was not totally inhibited, suggesting that there may be a PKC-independent pathway of tyrosine kinase activation.
The role of individual PKC isoforms in cells cannot be identified using PKC antagonists that block the activity of more than one isoenzyme. Ro31-8220 is known to be specific for PKC rather than other protein kinases [26] . In addition preferentially inhibits PKCa over PKCfl, y and e [27, 54] . The determination of PKC isoforms in the rat adrenal gland is unclear and requires thorough investigation. However, data presented here support the view that PKC is probably an important part of the signalling pathway activating tyrosine kinases in response to phospholipase C-linked agonists in the rat adrenal zona glomerulosa.
The precise mechanisms responsible for functional coupling of the activated AngIl receptor and tyrosine kinase activity are at present unknown. The rat adrenal zona glomerulosa tissue used in this study expresses the AT1-type receptor [55] [56] [57] [58] [59] . The receptor has recently been cloned [60, 61] and it appears not to have any intrinsic tyrosine kinase activity. Therefore the binding of AngIl to the AT1 receptor may rapidly induce additional coupling to intracellular tyrosine kinases. A recent study by Hausdorff et al. [62] has shown that src-tyrosine kinase can phosphorylate the ax-subunit of many trimeric G-proteins in vitro. mechanism stimulated by Angll and a-MSH in the rat adrenal zona glomerulosa. Further studies aimed at identification-of activated intracellular protein tyrosine kinases and defining the precise role of PKC in agonist-induced aldosterone secretion are being carried out. The results may provide a more complete understanding of the integrated cellular function of phospholipase C-coupled hormones in the rat adrenal cortex.
